Home / Stocks / ARDT

Ardent Health (ARDT, Health Care Facilities) Stock Valuation & Fair Value Quality business with a solid forward outlook

Ardent Health (ARDT, Health Care Facilities) trades at a blended P/E of 10.9, about 9% above its historical normal valuation, with a forward growth estimate of 11.4% and a PEG of 0.95. Priced at its historical normal P/E of 10.0 on the same blended earnings, the 2026-09-18 close of $10.48 corresponds to about $9.60 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-09-21
Blended P/E
10.9
Normal P/E
10.0
PEG
0.95
Fwd growth
11.4%
Div yield
0.0%
RSI (14)
42.1
Neutral

The Street vs SeerForecast

Wall Street's mean price target for ARDT is $12.82 across 11 analysts, 20.5% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: quality business with a solid forward outlook. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from high quality, attractively priced for its growth (2026-07-31) to quality business with a solid forward outlook (2026-09-21).

Blended P/E and rating by weekBlended P/E moved from 10.5 to 10.9 between 2026-07-31 and 2026-09-21, against a normal P/E of 10.0, with 1 rating change over 18 recorded weeks.2026-07-31: P/E 10.5, High quality, attractively priced for its growth (recalculated)2026-08-03: P/E 10.5, High quality, attractively priced for its growth2026-08-07: P/E 10.5, High quality, attractively priced for its growth (recalculated)2026-08-10: P/E 12.0, High quality, attractively priced for its growth2026-08-14: P/E 12.0, High quality, attractively priced for its growth (recalculated)2026-08-17: P/E 11.4, Quality business with a solid forward outlook2026-08-21: P/E 11.4, Quality business with a solid forward outlook (recalculated)2026-08-24: P/E 11.4, Quality business with a solid forward outlook2026-08-27: P/E 11.4, Quality business with a solid forward outlook (recalculated)2026-08-28: P/E 11.4, Quality business with a solid forward outlook (recalculated)2026-08-30: P/E 11.4, Quality business with a solid forward outlook (recalculated)2026-08-31: P/E 11.4, Quality business with a solid forward outlook2026-09-05: P/E 11.4, Quality business with a solid forward outlook (recalculated)2026-09-07: P/E 11.4, Quality business with a solid forward outlook2026-09-12: P/E 11.4, Quality business with a solid forward outlook (recalculated)2026-09-14: P/E 11.4, Quality business with a solid forward outlook2026-09-19: P/E 11.4, Quality business with a solid forward outlook (recalculated)2026-09-21: P/E 10.9, Quality business with a solid forward outlook10.011.012.0Jul 31Aug 13Aug 26Sep 8Sep 21Normal P/E 10.0
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-07-31P/E 10.5+5%High quality, attractively priced for its growth
2026-08-03P/E 10.5+5%High quality, attractively priced for its growth
2026-08-10P/E 12.0+20%High quality, attractively priced for its growth
2026-08-17P/E 11.4+14%Quality business with a solid forward outlook
2026-09-21P/E 10.9+9%Quality business with a solid forward outlook ← now

Frequently asked questions

Is Ardent Health stock overvalued?

At a blended P/E of 10.9 versus its historical normal P/E of 10.0, Ardent Health trades about 9% above its typical valuation, with a PEG of 0.95 on 11.4% forward growth. tickerseer currently rates it quality business with a solid forward outlook.

What is Ardent Health's fair value and PEG?

Ardent Health trades at a blended P/E of 10.9 against a historical normal P/E of 10.0, a PEG of 0.95, and a forward growth estimate of 11.4%. Priced at its historical normal P/E of 10.0 on the same blended earnings, the 2026-09-18 close of $10.48 corresponds to about $9.60 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Ardent Health changed?

tickerseer's rating moved from high quality, attractively priced for its growth (2026-07-31) to quality business with a solid forward outlook (2026-09-21).

What is the analyst price target for Ardent Health?

The mean Wall Street price target for Ardent Health is $12.82 across 11 analysts, 20.5% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Facilities. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track ARDT free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.